Key Highlights

● CB closed at $341.07 on 9 October 2026, down 0.8% on the day, and the $359.05 consensus target implies upside of about 5.3%.

● The consensus draws on 22 analysts, with targets from $271 to $400, while the second data set shows a $366.87 mean from 25 analysts.

● Market data shows one Strong Buy, eight Buy, 12 Hold and one Sell rating, a Hold consensus.

● JPMorgan cut its target to $371 from $374 on 9 October, Mizuho to $336 from $347 on 7 October and Morgan Stanley to $350 from $360 on 6 October.

Chubb Limited (NYSE:CB), a member of the S&P 500, closed at $341.07 on Friday 9 October 2026, down 0.8% on the day. The insurer has seen a run of target adjustments in October, mostly small reductions from analysts who rate the shares neutral.

What Is the Latest Analyst Price Target?

Market data reports a consensus target of $359.05 from 22 analysts, with a high of $400 and a low of $271. Compared with the $341.07 close on 9 October 2026, that suggests potential upside of about 5.3%, a narrower margin than for many large companies.

The second data set shows a slightly higher mean of $366.87 and a median of $365 across 25 analysts, with a range of $307 to $425, updated on 9 October. Recent named broker targets from July to October range from $301 to $400 and average around $362, so both data sets are consistent with them.

What Are Wall Street Analysts Saying?

The ratings are mixed, with Hold the most common. Market data counts one Strong Buy, eight Buy, 12 Hold and one Sell, a consensus of Hold. The second data set records seven Strong Buy, two Buy, 14 Hold and two Sell, and labels its consensus Buy.

October brought a series of modest target reductions. JPMorgan's Pablo Singzon lowered his target from $374 to $371 on 9 October with a Neutral rating. Mizuho cut from $347 to $336 (Neutral) on 7 October, and Morgan Stanley from $360 to $350 (Equal Weight) on 6 October. HSBC holds a Hold rating with a $359 target, and the second data set shows it lowering from $377.

Cantor Fitzgerald nudged its target up from $330 to $333, also with a Neutral rating. In July, Wells Fargo lowered its target from $358 to $356, while Piper Sandler lifted its target from $340 to $374, UBS from $340 to $369, KBW from $374 to $389 and Goldman Sachs from $362 to $386. Citizens JMP reiterated Market Outperform with a $400 target on 22 July.

What Could Help the Stock Reach the Price Target?

The gap between the share price and the consensus is small, so modest improvements in sentiment could be enough to narrow it. Several brokers with positive ratings, including KBW, Goldman Sachs, Evercore and Citizens JMP, hold targets of $374 to $400, which show that some analysts see more room.

What Could Prevent the Stock Reaching the Target?

The direction of recent revisions is slightly downward, and 12 to 14 analysts rate the stock Hold, which suggests that many see the shares as fairly valued. With only about 5% implied upside on market data's figures, a small disappointment could make the shares look expensive against targets. The low target of $271 on market data and the two Sell ratings on the second data set show that not everyone is optimistic. General risks for insurers include catastrophe losses, claims inflation and market volatility.

What Should Investors Watch Next?

Items to watch include whether the October trend of lower neutral targets continues, how brokers respond to the next results, and whether any of the Hold-rated analysts change their ratings.

Chubb's Narrow Target Gap Leaves Little Margin Against Small Cuts

Chubb closed at $341.07 on 9 October 2026, with the $359.05 consensus target only about 5.3% higher and the second data set's $366.87 mean slightly above that. Hold is the most common rating, 12 of 22 in market data, and the October pattern is slightly downward, with JPMorgan, Mizuho and Morgan Stanley all trimming neutral-rated targets. Yet KBW, Goldman Sachs, Evercore and Citizens JMP hold targets of $374 to $400, which show that some analysts see more room.